These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1562282)

  • 1. Effect of ethinylestradiol and epomediol on bile flow and biliary lipid composition in rat.
    Rodriguez JV; Torres AM; Lunazzi G; Tiribelli C
    Biochem Pharmacol; 1992 Mar; 43(6):1289-93. PubMed ID: 1562282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity.
    Miccio M; Orzes N; Lunazzi GC; Gazzin B; Corsi R; Tiribelli C
    Biochem Pharmacol; 1989 Oct; 38(20):3559-63. PubMed ID: 2554925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of epomediol on ethinyloestradiol-induced changes in bile acid and cholesterol metabolism in rats.
    Cuevas MJ; Mauriz JL; Almar M; Collado PS; González-Gallego J
    Clin Exp Pharmacol Physiol; 2001 Aug; 28(8):637-42. PubMed ID: 11473529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of epomediol on bile flow and composition in normal rats and in rats with ethynylestradiol-induced cholestasis.
    Zuin M; Dioguardi ML; Festorazzi S; Podda M
    Farmaco Prat; 1981 Aug; 36(8):383-9. PubMed ID: 7274418
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of bile acid pool size, synthesis and secretion by epomediol in the rat.
    Mauriz JL; Cuevas MJ; El-Mir MY; Almar M; Collado PS; Gonzalez-Gallego J
    Dig Dis Sci; 2000 Jul; 45(7):1431-8. PubMed ID: 10961725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of epomediol on taurocholate uptake in hepatocytes isolated from normal rats or rats with ethinyloestradiol-induced cholestasis.
    Barone M; Azzarone A; Angelini A; Zamparella M; Dell'Aquila P; Francavilla A
    Pharmacol Toxicol; 1993; 72(4-5):296-9. PubMed ID: 8372050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the terpenic compound epomediol on biliary secretion and bile composition in the rat.
    Zanninelli G; Tavanti A; Munoz ME; Ricci GL
    J Hepatol; 1992 Jan; 14(1):64-70. PubMed ID: 1737917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of epomediol on ethinyloestradiol-induced changes in glutathione homeostasis in the rat.
    Cuevas MJ; Almar M; González-Gallego J
    Pharmacol Toxicol; 2002 Mar; 90(3):121-6. PubMed ID: 12071332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
    Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
    Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
    Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
    Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis.
    Sánchez Pozzi EJ; Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Rodríguez Garay EA; Mottino AD
    J Pharmacol Exp Ther; 2003 Jul; 306(1):279-86. PubMed ID: 12663690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ethynylestradiol on biliary excretion of bile acids, phosphatidylcolines, and cholesterol in the bile fistula rat.
    Kern F; Eriksson H; Curstedt T; Sjövall J
    J Lipid Res; 1977 Sep; 18(5):623-34. PubMed ID: 903709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased biliary glutathione content is responsible for the decline in bile salt-independent flow induced by ethinyl estradiol in rats.
    Bouchard G; Yousef IM; Tuchweber B
    Toxicol Lett; 1994 Dec; 74(3):221-33. PubMed ID: 7871546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cicloxilic acid on bile flow and lipid composition in rats with ethinylestradiol-induced cholestasis.
    Subissi A; Barsacchi P; Sardelli G
    Arzneimittelforschung; 1982; 32(10):1310-1. PubMed ID: 6891234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the Cl-/HCO-3 exchanger in the rat.
    Alvaro D; Gigliozzi A; Piat C; Carli L; Fraioli F; Romeo R; Francia C; Attili AF; Capocaccia L
    J Hepatol; 1997 Jan; 26(1):146-57. PubMed ID: 9148006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of biliary epomediol-beta-glucuronide levels with bile flow enhancement in the rat.
    Ventura P; Lumachi B; Luzzani F; Scuri R
    Arzneimittelforschung; 1985; 35(10):1548-9. PubMed ID: 4074413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat.
    Galán AI; Román ID; Muñoz ME; Cava F; Gonzalez-Buitrago JM; Esteller A; Jimenez R
    Biochem Pharmacol; 1992 Sep; 44(6):1105-13. PubMed ID: 1417934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestasis, metabolism and biliary lipid secretion during perfusion of rat liver with different bile salts.
    Baumgartner U; Schölmerich J; Leible P; Farthmann EH
    Biochim Biophys Acta; 1992 Apr; 1125(2):142-9. PubMed ID: 1571357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of biliary cholesterol and phospholipid secretion during cyclobutyrol-induced hydrocholeresis.
    Monte MJ; Cava F; Esteller A; Jimenez R
    Biochem J; 1989 Oct; 263(2):513-8. PubMed ID: 2574569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of epomediol on the recovery time of taurocholic acid captation in the perfused rat liver after suspension of the treatment with ethynylestradiol.
    Chiarantini E; Chieca R; Orlandini F; Romeo D; Buzzelli G; Gentilini P
    Farmaco Prat; 1986 Nov; 41(11):358-62. PubMed ID: 3803561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.